Publications by authors named "Stuart Phillis"

Claim this Profile
P
Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline.
Susan Branford, David T Yeung, Wendy T Parker, Nicola D Roberts, Leanne Purins, Stuart Phillis

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination.
Wendy T Parker, Stuart R Phillis, David T O Yeung, Timothy P Hughes, Hamish S Scott

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML.
Susan Branford, David T Yeung, David M Ross, Jodi A Prime, Chani R Field, Stuart Phillis

Blood· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
Maria Caruso, James Moore, Gregory J Goodall, Michelle Thomas, Stuart Phillis

Virchows Arch· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis